\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ examination\\ reveals\\ exquisite\\ tenderness\\ and\\ nodularity\\ of\\ the\\ thyroid\\.\\ \\ esr\\ is\\ elevated\\,\\ t3\\ and\\ t4\\ are\\ elevated\\,\\ and\\ tsh\\ is\\ undetectable\\.\ \(0\)\
\-\ radioiodine\\ \\(i\\-131\\)\\ uptake\\ is\\ 0\\.5\\%\\ \\(\\ normal\\ approx\\.\\ 5\\-15\\%\\ at\\ 4\\ hours\\)\\.\\ \\ thyroid\\ imaging\\ demonstrates\\ near\\ absent\\ visualization\\ of\\ the\\ thyroid\\ gland\\ \\(\\ uptake\\ in\\ the\\ gland\\ slightly\\ greater\\ than\\ background\\ counts\\)\\ and\\ a\\ somewhat\\ heterogenous\\ pattern\\ of\\ uptake\\.\ \(0\)\
\-\ subacute\\ thyroiditis\ \(5\)\
\-\ disorders\\ associated\\ with\\ low\\ thyroid\\ uptakes\\:\\ \ \(0\)\
\-\ \\ \\ \ \(31891\)\
\-\ \\*\\ subacute\\ thyroiditis\ \(0\)\
\-\ \\*\\ medicines\\:\\ thyroxine\\,\\ glucocorticoids\\,\\ phenylbutazone\\,\\ \\ \\ \\ \\ sulfonylureas\ \(0\)\
\-\ \\*\\ primary\\ or\\ secondary\\ hypothyroidism\ \(0\)\
\-\ \\*\\ ectopic\\ hormone\\ production\ \(0\)\
\-\ \\*\\ ectopic\\ thyroid\\ \\(lingual\\,\\ substernal\\)\ \(0\)\
\-\ \\*\\ recent\\ high\\ dose\\ of\\ iodine\\ \\(as\\ in\\ the\\ setting\\ of\\ contrast\\-enhanced\\ ct\\)\ \(0\)\
\-\ 52\\ year\\ old\\ male\\ patient\\ with\\ 1\\ month\\ history\\ of\\ weight\\ loss\\ despite\\ good\\ appetite\\,\\ \\ nervousness\\,\\ tremors\\,\\ and\\ inability\\ to\\ sleep\\.\\ \\ symptoms\\ followed\\ an\\ upper\\ respiratory\\ tract\\ infection\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ thyroid\\:\\ 0\\.3791425668224727\ \(0\)\
\-\ uptake\\:\\ 0\\.22258224704861396\ \(0\)\
\-\ thyroiditis\\:\\ 0\\.2137756000189369\ \(0\)\
\-\ subacute\\:\\ 0\\.18059438819373508\ \(0\)\
\-\ ectopic\\:\\ 0\\.17067050410099938\ \(0\)\
\-\ gland\\:\\ 0\\.1567631287886561\ \(0\)\
\-\ phenylbutazone\\:\\ 0\\.15430629529578618\ \(0\)\
\-\ sulfonylureas\\:\\ 0\\.15430629529578618\ \(0\)\
\-\ uptakes\\:\\ 0\\.1474479029718653\ \(0\)\
\-\ thyroxine\\:\\ 0\\.1474479029718653\ \(0\)\
\-\ undetectable\\:\\ 0\\.138807350512875\ \(0\)\
\-\ medicines\\:\\ 0\\.138807350512875\ \(0\)\
\-\ elevated\\:\\ 0\\.13155514253669812\ \(0\)\
\-\ radioiodine\\:\\ 0\\.12886501152968352\ \(0\)\
\-\ lingual\\:\\ 0\\.12886501152968352\ \(0\)\
\-\ tremors\\:\\ 0\\.12886501152968352\ \(0\)\
\-\ nervousness\\:\\ 0\\.12708285139461412\ \(0\)\
\-\ exquisite\\:\\ 0\\.1254706914516502\ \(0\)\
\-\ counts\\:\\ 0\\.12022445907069322\ \(0\)\
\-\ glucocorticoids\\:\\ 0\\.1191327979410035\ \(0\)\
\-\ substernal\\:\\ 0\\.11622597202824156\ \(0\)\
\-\ of\\:\\ 0\\.11329436505829733\ \(0\)\
\-\ approx\\:\\ 0\\.11028212008750174\ \(0\)\
\-\ background\\:\\ 0\\.10849995995243232\ \(0\)\
\-\ nodularity\\:\\ 0\\.10688780000946844\ \(0\)\
\-\ iodine\\:\\ 0\\.1063828408176224\ \(0\)\
\-\ t3\\:\\ 0\\.10450147290998066\ \(0\)\
\-\ production\\:\\ 0\\.1036338531580923\ \(0\)\
\-\ appetite\\:\\ 0\\.10126979713059721\ \(0\)\
\-\ hypothyroidism\\:\\ 0\\.10054990649882171\ \(0\)\
\-\ and\\:\\ 0\\.0996909512231798\ \(0\)\
\-\ inability\\:\\ 0\\.09952444849370151\ \(0\)\
\-\ sleep\\:\\ 0\\.09855762096924084\ \(0\)\
\-\ hormone\\:\\ 0\\.09824724755047815\ \(0\)\
\-\ t4\\:\\ 0\\.09677546083417142\ \(0\)\
\-\ tsh\\:\\ 0\\.0932280639038483\ \(0\)\
\-\ visualization\\:\\ 0\\.09233760164108157\ \(0\)\
\-\ heterogenous\\:\\ 0\\.09088389603471121\ \(0\)\
\-\ dose\\:\\ 0\\.09010606351258893\ \(0\)\
\-\ setting\\:\\ 0\\.08973016189321448\ \(0\)\
\-\ 52\\:\\ 0\\.089362432699043\ \(0\)\
\-\ esr\\:\\ 0\\.08830490856728665\ \(0\)\
\-\ somewhat\\:\\ 0\\.08779994937544063\ \(0\)\
\-\ disorders\\:\\ 0\\.08519250962757353\ \(0\)\
\-\ despite\\:\\ 0\\.08395930058622082\ \(0\)\
\-\ tract\\:\\ 0\\.08083136202507957\ \(0\)\
\-\ is\\:\\ 0\\.07927218534674065\ \(0\)\
\-\ absent\\:\\ 0\\.07915939691645033\ \(0\)\
\-\ near\\:\\ 0\\.07857269497860664\ \(0\)\
\-\ good\\:\\ 0\\.0784768597265788\ \(0\)\
\-\ the\\:\\ 0\\.07701189684652897\ \(0\)\
\-\ respiratory\\:\\ 0\\.07675213556090575\ \(0\)\
\-\ slightly\\:\\ 0\\.075265971557941\ \(0\)\
\-\ hours\\:\\ 0\\.07353923114815285\ \(0\)\
\-\ reveals\\:\\ 0\\.07339708849038001\ \(0\)\
\-\ pattern\\:\\ 0\\.07203773271379943\ \(0\)\
\-\ greater\\:\\ 0\\.07108542439772794\ \(0\)\
\-\ weight\\:\\ 0\\.06728630348911778\ \(0\)\
\-\ recent\\:\\ 0\\.06533241724216837\ \(0\)\
\-\ followed\\:\\ 0\\.06515758491841026\ \(0\)\
\-\ examination\\:\\ 0\\.06174351139105174\ \(0\)\
\-\ tenderness\\:\\ 0\\.060510302349699015\ \(0\)\
\-\ primary\\:\\ 0\\.059330086844790485\ \(0\)\
\-\ loss\\:\\ 0\\.058784398337010185\ \(0\)\
\-\ month\\:\\ 0\\.0586951375666268\ \(0\)\
\-\ infection\\:\\ 0\\.058284704476485996\ \(0\)\
\-\ secondary\\:\\ 0\\.05719123320427918\ \(0\)\
\-\ low\\:\\ 0\\.05536568766104513\ \(0\)\
\-\ high\\:\\ 0\\.05483780469576353\ \(0\)\
\-\ than\\:\\ 0\\.05469665052417515\ \(0\)\
\-\ symptoms\\:\\ 0\\.052793102400546396\ \(0\)\
\-\ physical\\:\\ 0\\.05231834010022534\ \(0\)\
\-\ upper\\:\\ 0\\.051562019627937765\ \(0\)\
\-\ associated\\:\\ 0\\.050856733869772026\ \(0\)\
\-\ imaging\\:\\ 0\\.050708030698998964\ \(0\)\
\-\ demonstrates\\:\\ 0\\.048474829153001886\ \(0\)\
\-\ in\\:\\ 0\\.04800647013872707\ \(0\)\
\-\ male\\:\\ 0\\.042960441556547435\ \(0\)\
\-\ normal\\:\\ 0\\.039395653061007264\ \(0\)\
\-\ as\\:\\ 0\\.03876289962567436\ \(0\)\
\-\ with\\:\\ 0\\.0377873528048077\ \(0\)\
\-\ an\\:\\ 0\\.03689692112133217\ \(0\)\
\-\ history\\:\\ 0\\.03686423535901675\ \(0\)\
\-\ ct\\:\\ 0\\.03673412028099942\ \(0\)\
\-\ are\\:\\ 0\\.036613039758726124\ \(0\)\
\-\ at\\:\\ 0\\.03644497004787523\ \(0\)\
\-\ or\\:\\ 0\\.033566669800769035\ \(0\)\
\-\ patient\\:\\ 0\\.03138290145770339\ \(0\)\
\-\ year\\:\\ 0\\.02973589034185046\ \(0\)\
\-\ old\\:\\ 0\\.028556748062063566\ \(0\)\
\-\ to\\:\\ 0\\.024121963322880448\ \(0\)\
